405 related articles for article (PubMed ID: 19755971)
21. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease.
Ordás I; Rimola J; Rodríguez S; Paredes JM; Martínez-Pérez MJ; Blanc E; Arévalo JA; Aduna M; Andreu M; Radosevic A; Ramírez-Morros AM; Pinó S; Gallego M; Jauregui-Amezaga A; Ricart E; Panés J
Gastroenterology; 2014 Feb; 146(2):374-82.e1. PubMed ID: 24177375
[TBL] [Abstract][Full Text] [Related]
22. Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI).
Dewint P; Hansen BE; Verhey E; Oldenburg B; Hommes DW; Pierik M; Ponsioen CI; van Dullemen HM; Russel M; van Bodegraven AA; van der Woude CJ
Gut; 2014 Feb; 63(2):292-9. PubMed ID: 23525574
[TBL] [Abstract][Full Text] [Related]
23. Thalidomide in luminal and fistulizing Crohn's disease resistant to standard therapies.
Plamondon S; Ng SC; Kamm MA
Aliment Pharmacol Ther; 2007 Mar; 25(5):557-67. PubMed ID: 17305756
[TBL] [Abstract][Full Text] [Related]
24. Mucosal healing at 3 months predicts long-term endoscopic remission in anti-TNF-treated luminal Crohn's disease.
af Björkesten CG; Nieminen U; Sipponen T; Turunen U; Arkkila P; Färkkilä M
Scand J Gastroenterol; 2013 May; 48(5):543-51. PubMed ID: 23477356
[TBL] [Abstract][Full Text] [Related]
25. Anti-TNF-alpha (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn's disease: a preliminary report.
van der Hagen SJ; Baeten CG; Soeters PB; Russel MG; Beets-Tan RG; van Gemert WG
Dis Colon Rectum; 2005 Apr; 48(4):758-67. PubMed ID: 15750797
[TBL] [Abstract][Full Text] [Related]
26. Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn's disease.
Hukkinen M; Pakarinen MP; Piekkala M; Koivusalo A; Rintala R; Kolho KL
J Crohns Colitis; 2014 Aug; 8(8):756-62. PubMed ID: 24447625
[TBL] [Abstract][Full Text] [Related]
27. Long-term outcome of enterocutaneous fistula in patients with Crohn's disease treated with anti-TNF therapy: a cohort study from the GETAID.
Amiot A; Setakhr V; Seksik P; Allez M; Treton X; De Vos M; Laharie D; Colombel JF; Abitbol V; Reimund JM; Moreau J; Veyrac M; Flourié B; Cosnes J; Lemann M; Bouhnik Y
Am J Gastroenterol; 2014 Sep; 109(9):1443-9. PubMed ID: 25091063
[TBL] [Abstract][Full Text] [Related]
28. Biological immunomodulators improve the healing rate in surgically treated perianal Crohn's fistulas.
El-Gazzaz G; Hull T; Church JM
Colorectal Dis; 2012 Oct; 14(10):1217-23. PubMed ID: 22251452
[TBL] [Abstract][Full Text] [Related]
29. Combined modality treatment for complex fistulating perianal Crohn's disease.
Antakia R; Shorthouse AJ; Robinson K; Lobo AJ
Colorectal Dis; 2013 Feb; 15(2):210-6. PubMed ID: 22672653
[TBL] [Abstract][Full Text] [Related]
30. Infliximab and surgical treatment of complex anal Crohn's disease.
Duff S; Sagar PM; Rao M; Dolling S; Sprakes M; Hamlin PJ
Colorectal Dis; 2012 Aug; 14(8):972-6. PubMed ID: 21899707
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of short-term adalimumab treatment in patients with active Crohn's disease who lost response or showed intolerance to infliximab: a prospective, open-label, multicentre trial.
Hinojosa J; Gomollón F; García S; Bastida G; Cabriada JL; Saro C; Ceballos D; Peñate M; Gassull MA;
Aliment Pharmacol Ther; 2007 Feb; 25(4):409-18. PubMed ID: 17269996
[TBL] [Abstract][Full Text] [Related]
32. [The use of adalimumab in severe fistulising Crohn's disease].
Bang UC; Nielsen AM
Ugeskr Laeger; 2008 Jun; 170(25):2256. PubMed ID: 18565318
[TBL] [Abstract][Full Text] [Related]
33. [Treatment with chimeric monoclonal antitumor necrosis factor (infliximab) of patients with active steroid-dependent/resistant Crohn's disease and fistulas].
Martorana G; Casà A; Oliva L; Orlando A; Cottone M
Recenti Prog Med; 2001; 92(7-8):451-5. PubMed ID: 11475786
[TBL] [Abstract][Full Text] [Related]
34. Predicting factors of fistula healing and clinical remission after infliximab-based combined therapy for perianal fistulizing Crohn's disease.
Tougeron D; Savoye G; Savoye-Collet C; Koning E; Michot F; Lerebours E
Dig Dis Sci; 2009 Aug; 54(8):1746-52. PubMed ID: 19003531
[TBL] [Abstract][Full Text] [Related]
35. Mucosal healing with thalidomide in refractory Crohn's disease patients intolerant of anti-TNF-α drugs: report of 3 cases and literature review.
Scribano ML; Cantoro L; Marrollo M; Cosintino R; Kohn A
J Clin Gastroenterol; 2014 Jul; 48(6):530-3. PubMed ID: 24667589
[TBL] [Abstract][Full Text] [Related]
36. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience.
Topstad DR; Panaccione R; Heine JA; Johnson DR; MacLean AR; Buie WD
Dis Colon Rectum; 2003 May; 46(5):577-83. PubMed ID: 12792431
[TBL] [Abstract][Full Text] [Related]
37. Optimizing anti-TNF treatment in inflammatory bowel disease.
Rutgeerts P; Van Assche G; Vermeire S
Gastroenterology; 2004 May; 126(6):1593-610. PubMed ID: 15168370
[TBL] [Abstract][Full Text] [Related]
38. Outcome of surgery for rectovaginal fistula due to Crohn's disease.
Ruffolo C; Penninckx F; Van Assche G; Vermeire S; Rutgeerts P; Coremans G; D'Hoore A
Br J Surg; 2009 Oct; 96(10):1190-5. PubMed ID: 19688772
[TBL] [Abstract][Full Text] [Related]
39. [Predictors of efficacy, mucosal healing and dose intensification during the first year of adalimumab therapy in patients with luminal and fistulizing Crohn's disease. National data from Hungary].
Kiss LS; Szamosi T; Molnár T; Miheller P; Lakatos L; Vincze A; Palatka K; Bartha Z; Gasztonyi B; Salamon A; Horváth G; Tóth GT; Farkas K; Banai J; Tulassay Z; Nagy F; Szenes M; Veres G; Lovász BD; Végh Z; Golovics PA; Szathmári M; Papp M; Lakatos PL
Orv Hetil; 2011 Sep; 152(36):1433-42. PubMed ID: 21865144
[TBL] [Abstract][Full Text] [Related]
40. High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease.
Martínez-Borra J; López-Larrea C; González S; Fuentes D; Dieguez A; Deschamps EM; Pérez-Pariente JM; López-Vázquez A; de Francisco R; Rodrigo L
Am J Gastroenterol; 2002 Sep; 97(9):2350-6. PubMed ID: 12358255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
